(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2(Date:9/3/2008)...l Vascular Disease Awareness Month, CHARLOTTESVIL...euticals,LLC, a clinical-stage drug-development co...of unmet medical needs, announced today that it ha...l trial of its lead drug,candidate trans sodium cr...,on the clinicaltrials.gov Website, is investigati...
(Date:9/3/2008)...taq(R) (dronedarone) decreased the risk of,stroke ...al flutter already adequately treated...pt. 3 /- The results of a,p... were presented today at,the clinical trial update...gress 2008, in Munich, Germany. Previous results f...
(Date:9/3/2008)...s Strong Evidence Pycnogenol(R) Lowers Joint, Pain...Following Cessation of... -- According to the Center for,Disease Control (C...itis,is on the rise. A new study published in the...Pycnogenol(R), bark extract from the French mariti...
(Date:9/2/2008)...re-FirstCall/ -- Forest Laboratories, Inc.,(NYSE: ...nced results from,two global Phase III studies of ...ticholinergic for the treatment of patients with c...th the ACCLAIM/COPD I&II,(AClidinium CLinical Tria...ere COPD Patients) studies, once-daily aclidinium ...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 1AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 2AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 1Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 2Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 4Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 1Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 2Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 3Spiritual Healer Psychic Medium Reaches International Status 21 1230 1Spiritual Healer Psychic Medium Reaches International Status 21 1230 2... Nasalfent shows clinically meaningful pain relief..., READING, England, 7 June 2007 - Archimedes Pharm...eutical company, today,presented new clinical data...ive fentanyl citrate nasal spray aimed at providin...reakthrough cancer,pain. Data were presented at th...
...Orexigen(TM) is evaluating zonisamide SR as a nove..., SAN DIEGO, June 07, 2007 /PRNewswire-FirstCall/ ...utical company focused on the,treatment of central... obesity, today announced results from a Phase I t... novel, proprietary,sustained-release (SR) formul...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4The MediLive ImageBox is the first, easy-to-use digital,recording device that integrates with the surgical microscope and video camera., ,It simplifies image capturing by burning the still imag
With MediLive MindStream you can make, cut and edit digital videos, add commentaries and notes, and save them. MediLive MindStream - intuitive user interface and high-resolution monitor all in one.
The VISUCAM non-mydriatic fundus camera increases the quality and simplicity of fundus imaging. Compact, yet big enough to set the standard in ophthalmic photography, it features a unique combination
...er Monitoring System, equipped with the latest Epi...is algorithm, Heart Rate Variability analysis and ...ith an Epicardia System in place have complete con...t their needs, and managing their data. The Epicar...
Medicine Products: